Cheaper Cancer Medicines: What the New Margin Cap Means for Patients

Key Highlights:

• The National Pharmaceutical Pricing Authority (NPPA) capped the trade margin on 137 non-scheduled anti-cancer medicines at 30% of the Maximum Retail Price (MRP).
• This order, issued on October 17, 2026, became effective from November 9, 2026.
• The measure is estimated to save patients Rs. 3,357.49 crore, with average MRP reductions ranging from 20% to 70%.
• The decision was made by invoking extraordinary public-interest powers under Paragraph 19 of the Drugs (Prices Control) Order (DPCO), 2013.

Detailed Insights:

• The cap aims to make cancer treatment more affordable by addressing excessive markups along the pharmaceutical supply chain.
• This initiative builds on a successful 2019 Trade Margin Rationalisation (TMR) pilot for 42 non-scheduled anti-cancer drugs.
• Medicine prices in India are regulated under the Drugs (Prices Control) Order (DPCO), 2013, mandated by the Essential Commodities Act.
• The DPCO categorizes medicines into scheduled (listed in National List of Essential Medicines - NLEM) and non-scheduled drugs.
• NLEM 2022 includes 63 anti-cancer medicines among its 388 listed essential drugs.
• Complementary government programs include Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) for cashless treatment.
• The National Programme for the Prevention and Control of Non-Communicable Diseases (NP-NCD) strengthens cancer care infrastructure and screening.
• Ayushman Arogya Mandirs provide screening for common cancers, and a nationwide Human Papillomavirus (HPV) Vaccination Campaign was launched for girls.
• Affordable medicine access is further enhanced through Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) and Affordable Medicines and Reliable Implants for Treatment (AMRIT) pharmacies.

Key Concepts Involved:

• Trade Margin: The difference between a manufacturer's price to a distributor and the patient's Maximum Retail Price (MRP), excluding GST.
• Drugs (Prices Control) Order (DPCO): A government order under the Essential Commodities Act that regulates the prices of pharmaceutical drugs.
• National List of Essential Medicines (NLEM): An official list of necessary, high-priority medicines in India, whose prices are subject to government ceiling.
• Non-scheduled medicines: Drugs not included in the NLEM, whose prices are typically monitored for annual increases rather than fixed.